Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Malignant Melanoma

  Free Subscription


19.05.2025

3 Ann Surg Oncol
1 Br J Dermatol
1 J Clin Invest
1 J Invest Dermatol
1 Nat Rev Cancer


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Surg Oncol

  1. RHODIN KE, O'Connor MH, Therien A, Hollander S, et al
    ASO Visual Abstract: Circulating Tumor DNA in High-Risk Stage II/III Cutaneous Melanoma: A Feasibility Study.
    Ann Surg Oncol. 2025 May 11. doi: 10.1245/s10434-025-17411.
    PubMed        

  2. DUGAN MM, Boby A, Ghali H, Aflatooni S, et al
    Isolated Limb Infusion or Perfusion as First-Line Versus Second-Line Therapy for In-Transit Metastatic Melanoma.
    Ann Surg Oncol. 2025 May 10. doi: 10.1245/s10434-025-17403.
    PubMed         Abstract available

  3. DUGAN MM, Beekman KE, Zager JS
    ASO Author Reflections: Successful Radar-Guided Localization for Targeted Melanoma Metastasectomy After Neoadjuvant Immunotherapy.
    Ann Surg Oncol. 2025 May 9. doi: 10.1245/s10434-025-17427.
    PubMed        


    Br J Dermatol

  4. WANG Y, Xu G, Xia H
    Targeting the MAPK Pathway for NRAS Mutant Melanoma: From Mechanism to Clinic.
    Br J Dermatol. 2025 May 9:ljaf178. doi: 10.1093.
    PubMed         Abstract available


    J Clin Invest

  5. WANG Y, Ohnuki H, Tran AD, Wang D, et al
    Induced clustering of SHP2-depleted tumor cells in vascular islands restores sensitivity to MEK/ERK inhibition.
    J Clin Invest. 2025;135:e181609.
    PubMed         Abstract available


    J Invest Dermatol

  6. POLO-SILVEIRA L, Dusza SW, Kentley J, Marchetti MA, et al
    Cutaneous Melanoma Risk Assessment Among Individuals with a High-Risk Nevus Phenotype.
    J Invest Dermatol. 2025 May 13:S0022-202X(25)00478.
    PubMed        


    Nat Rev Cancer

  7. BREWER G
    Ageing lipids map melanoma's journey.
    Nat Rev Cancer. 2025 May 15. doi: 10.1038/s41568-025-00833.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.